Docusign FY2027 Earnings Forecast Raised by Zacks Research

Docusign Inc. (NASDAQ:DOCU) – Investment analysts at Zacks Research upped their FY2027 earnings estimates for Docusign in a research note issued to investors on Thursday, September 24th. Zacks Research analyst Team now forecasts that the company will earn $1.96 per share for the year, up from their previous forecast of $1.69. The consensus estimate for Docusign’s current full-year earnings is $2.13 per share. Zacks Research also issued estimates for Docusign’s Q1 2028 earnings at $0.49 EPS, Q2 2028 earnings at $0.49 EPS, Q3 2028 earnings at $0.51 EPS, Q4 2028 earnings at $0.57 EPS, FY2028 earnings at $2.07 EPS, Q1 2029 earnings at $0.66 EPS, Q2 2029 earnings at $0.67 EPS and FY2029 earnings at $1.95 EPS.

Docusign (NASDAQ:DOCU) last posted its earnings results on Thursday, September 3rd. The company reported $1.16 EPS for the quarter, topping analysts’ consensus estimates of $1.09 by $0.07. Docusign had a return on equity of 18.29% and a net margin of 9.82%.The business had revenue of $875.75 million for the quarter, compared to analysts’ expectations of $867.22 million. During the same quarter in the previous year, the firm earned $0.30 earnings per share. The business’s revenue was up 9.4% compared to the same quarter last year.

DOCU has been the topic of several other research reports. Evercore set a $65.00 price target on Docusign in a research report on Friday, September 4th. Wall Street Zen lowered shares of Docusign from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 2nd. Citizens Jmp restated a “market outperform” rating and set a $86.00 target price on shares of Docusign in a research report on Friday, September 4th. Piper Sandler lifted their target price on shares of Docusign from $52.00 to $75.00 and gave the company a “neutral” rating in a report on Friday, September 4th. Finally, Weiss Ratings upgraded shares of Docusign from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, August 25th. Three equities research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $67.33.

Docusign Price Performance

Shares of NASDAQ DOCU opened at $66.98 on Tuesday. The business has a 50-day moving average price of $62.31 and a 200 day moving average price of $52.56. The stock has a market cap of $12.52 billion, a PE ratio of 40.84, a price-to-earnings-growth ratio of 2.48 and a beta of 0.90. Docusign has a 52-week low of $40.16 and a 52-week high of $81.88.

Institutional Investors Weigh In On Docusign

Several hedge funds have recently modified their holdings of the stock. Greenwich Wealth Management LLC grew its position in Docusign by 30.0% in the 2nd quarter. Greenwich Wealth Management LLC now owns 120,835 shares of the company’s stock valued at $5,367,000 after buying an additional 27,855 shares during the last quarter. QRG Capital Management Inc. raised its position in Docusign by 31.2% during the 2nd quarter. QRG Capital Management Inc. now owns 11,132 shares of the company’s stock worth $495,000 after buying an additional 2,645 shares during the last quarter. Envestnet Portfolio Solutions Inc. raised its position in Docusign by 3.1% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 11,867 shares of the company’s stock worth $527,000 after buying an additional 356 shares during the last quarter. Integrated Wealth Concepts LLC lifted its stake in shares of Docusign by 2.0% in the 2nd quarter. Integrated Wealth Concepts LLC now owns 14,359 shares of the company’s stock worth $638,000 after acquiring an additional 277 shares during the period. Finally, NewEdge Advisors LLC lifted its stake in shares of Docusign by 29.8% in the 2nd quarter. NewEdge Advisors LLC now owns 14,311 shares of the company’s stock worth $636,000 after acquiring an additional 3,287 shares during the period. 77.64% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Docusign

In other Docusign news, Director Peter Solvik sold 46,000 shares of Docusign stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $65.24, for a total value of $3,001,040.00. Following the transaction, the director directly owned 49,558 shares in the company, valued at approximately $3,233,163.92. This trade represents a 48.14% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Mary Wilderotter sold 1,096 shares of Docusign stock in a transaction that occurred on Wednesday, September 16th. The shares were sold at an average price of $70.60, for a total value of $77,377.60. Following the completion of the transaction, the director owned 3,199 shares in the company, valued at $225,849.40. This trade represents a 25.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 123,318 shares of company stock worth $8,181,555 over the last three months. 0.59% of the stock is currently owned by company insiders.

Key Headlines Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Improved long-term earnings outlook: Zacks Research raised its FY2027 EPS estimate to $1.96 from $1.69, FY2028 to $2.07 from $1.76, and FY2029 to $1.95 from $1.35. The revisions suggest analysts see stronger profitability ahead. Docusign Stock Earnings Estimates Lifted by Zacks Research
• Positive Sentiment: Several quarterly estimates were increased: Zacks lifted estimates for Q1 2028 EPS to $0.49 from $0.47, Q2 2028 to $0.49 from $0.28, Q3 2028 to $0.51 from $0.38, and Q2 2029 to $0.67 from $0.21. The broad upward revisions may support investor confidence in Docusign’s earnings trajectory. DOCU Stock Soars 50.8% in 3 Months
• Positive Sentiment: Operating performance remains a catalyst: The recent rally reflects expectations that customer expansion, cost discipline and cash generation can drive margin gains and fund buybacks. Docusign’s latest reported quarter also exceeded revenue and EPS expectations, with revenue up 9.4% year over year.
• Neutral Sentiment: Mixed estimate revisions: Zacks reduced its Q1 2029 EPS forecast to $0.66 from $0.73 and Q4 2028 to $0.57 from $0.62. However, these cuts were offset by increases elsewhere, while the current-year consensus remains $2.10 per share.

Docusign Company Profile

DocuSign, Inc (NASDAQ:DOCU) provides cloud-based software for electronically signing, managing and automating agreements. Its platform enables individuals and organizations to prepare, send, sign, track and store documents digitally, helping replace paper-based contracting processes.

The company’s offerings include electronic signature tools, contract lifecycle management, identity verification and authentication services, document generation, agreement analytics and related workflow automation capabilities.